Literature DB >> 29862841

Factors Influencing Functional Outcomes of Subtalar Fusion for Posttraumatic Arthritis After Calcaneal Fracture.

Quirine M J van der Vliet1, Falco Hietbrink2, Fabio Casari3, Luke P H Leenen2, Marilyn Heng1.   

Abstract

BACKGROUND: Subtalar arthrodesis is a common salvage operation for posttraumatic subtalar arthritis. This study aimed to identify factors associated with functional outcomes and quality of life after subtalar fusion for posttraumatic subtalar arthritis after calcaneal fracture.
METHODS: This is a retrospective study with follow-up by questionnaire in two level 1 trauma centers. Patients who underwent subtalar arthrodesis for posttraumatic arthritis after a calcaneal fracture between 2001 and 2016 were identified and contacted for completion of a survey consisting of the Foot and Ankle Ability Measure (FAAM), Maryland Foot Score (MFS), Patient-Reported Outcomes Measurement System Physical Function (PROMIS PF, Short Form 10a) questionnaire, EuroQol 5-dimensional (EQ-5D) questionnaire, and EuroQol visual analog scale (EQ-VAS). Exclusion criteria were initial subtalar arthrodesis at an outside facility, primary arthrodesis for fracture, initial arthrodesis earlier than 2001, amputation of the fused foot or leg, younger than 18 years at time of fusion, and inability to communicate in English. A total of 159 patients met our inclusion criteria. Eighty-four patients completed the questionnaires, resulting in a response rate of 59%.
RESULTS: Median FAAM score was 79 (interquartile range [IQR], 48-90), median MFS was 74 (IQR, 56-86), and median PROMIS PF was 45 (IQR, 38-51). Quality of life was significantly lower when compared to a reference population ( P = .001). Smoking was independently associated with worse outcomes. Complications after fusion (such as nonunion, implant failure, and infectious complications), high-energy trauma, and ipsilateral injury were also predictors for poorer outcomes.
CONCLUSION: Acceptable functional outcomes and quality of life were observed after subtalar fusion. Smoking, complications after subtalar fusion, high-energy trauma, and presence of ipsilateral injuries were independently associated with worse functionality and quality of life. LEVEL OF EVIDENCE: Prognostic level III, comparative series.

Entities:  

Keywords:  calcaneal fracture; functional outcome; outcome studies; posttraumatic arthritis; quality of life; subtalar fusion; trauma

Mesh:

Year:  2018        PMID: 29862841     DOI: 10.1177/1071100718777492

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  5 in total

1.  Comparison of Patient-Reported Outcomes for Major Pathologies of the Forefoot, Midfoot, Hindfoot, and Achilles Using PROMIS.

Authors:  Daniel A Hu; Rusheel Nayak; Elijah O Ogunkoya; Milap S Patel; Anish R Kadakia
Journal:  Foot Ankle Orthop       Date:  2020-11-06

2.  Evaluating Prospective Patient-Reported Pain and Function Outcomes After Ankle and Hindfoot Arthrodesis.

Authors:  Manish P Mehta; Mitesh P Mehta; Alain E Sherman; Muhammad Y Mutawakkil; Raheem Bell; Milap S Patel; Anish R Kadakia
Journal:  Foot Ankle Orthop       Date:  2021-10-29

Review 3.  There are more things in physical function and pain: a systematic review on physical, mental and social health within the orthopedic fracture population using PROMIS.

Authors:  Thymen Houwen; Leonie de Munter; Koen W W Lansink; Mariska A C de Jongh
Journal:  J Patient Rep Outcomes       Date:  2022-04-06

4.  [A comparative study on internal fixation of calcaneal fractures assisted by robot and traditional open reduction internal fixation].

Authors:  Xinwei Yuan; Bin Zhang; Jiang Hu; Bing Lu; Zhi Tang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-06-15

5.  Long-term outcomes after operative treatment for tibial pilon fractures.

Authors:  Quirine M J van der Vliet; Yassine Ochen; Michael F McTague; Michael J Weaver; Falco Hietbrink; Roderick M Houwert; Luke P H Leenen; Marilyn Heng
Journal:  OTA Int       Date:  2019-11-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.